Follow
Iris Lafeber
Iris Lafeber
PhD candidate, Leiden University Medical Center
Verified email at lumc.nl
Title
Cited by
Cited by
Year
3D printing of pediatric medication: the end of bad tasting oral liquids?—a scoping review
I Lafeber, EJ Ruijgrok, HJ Guchelaar, KJM Schimmel
Pharmaceutics 14 (2), 416, 2022
392022
3D printed furosemide and sildenafil tablets: Innovative production and quality control
I Lafeber, JM Tichem, N Ouwerkerk, AD Van Unen, JJD Van Uitert, ...
International Journal of Pharmaceutics 603, 120694, 2021
322021
Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine
M Lyousoufi, I Lafeber, D Kweekel, BCM de Winter, JJ Swen, ...
Clinical Pharmacology & Therapeutics 113 (5), 1125-1131, 2023
152023
Rui grok, E
I Lafeber
Guchelaar, H.., & Schimmel, K.. M. D 3, 2022
2022
NP-015 Quality assessment of 3D printed sildenafil and furosemide tablets for the paediatric population using an innovative extrusion-based technique
I Lafeber, JM Tichem, HCM Bijleveld-Olierook, DM Kweekel, PPH Le Brun, ...
European Journal of Hospital Pharmacy 28 (Suppl 1), A173-A173, 2021
2021
Tichem
I Lafeber
M., Ouwerkerk, N., Unen,. D. an, Uitert,.. D. an, Bi le eld-Olierook, HCM …, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–6